These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9598116)

  • 21. Study of DNA repair in the peripheral blood lymphocytes of patients with rheumatic diseases under going treatment.
    Luksiene A; Filipaviciute R
    Adv Exp Med Biol; 1991; 309A():383-5. PubMed ID: 1789249
    [No Abstract]   [Full Text] [Related]  

  • 22. Simultaneous determination of azathioprine and 6-mercaptopurine by high-performance liquid chromatography.
    Van Os EC; McKinney JA; Zins BJ; Mays DC; Schriver ZH; Sandborn WJ; Lipsky JJ
    J Chromatogr B Biomed Appl; 1996 Apr; 679(1-2):147-54. PubMed ID: 8998554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of weather exposure on rheumatoid arthritis.
    Patberg WR
    J Rheumatol; 2003 Dec; 30(12):2728-9. PubMed ID: 14719227
    [No Abstract]   [Full Text] [Related]  

  • 24. Azathioprine in connective tissue disorders.
    Br Med J; 1972 Mar; 1(5801):645-6. PubMed ID: 5015288
    [No Abstract]   [Full Text] [Related]  

  • 25. [Transformation of lymphocytes during immunosuppressive therapy in lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 May; 24(10):152-4. PubMed ID: 5812420
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
    Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
    Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azathioprine, 6-mercaptopurine and thiopurine S-methyltransferase.
    Roberts-Thomson IC; Butler WJ
    J Gastroenterol Hepatol; 2005 Jun; 20(6):955. PubMed ID: 15946151
    [No Abstract]   [Full Text] [Related]  

  • 28. Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levelswith azathioprine.
    Lambert-Fliszar F; Bernatsky S; Kalache F; Grenier LP; Pineau CA; Vinet E
    Lupus Sci Med; 2021 Aug; 8(1):. PubMed ID: 34413183
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experience with treatment of rheumatic diseases with immunossuppressive substances].
    Mathies H
    Z Rheumaforsch; 1969; 28(1):7-11. PubMed ID: 5810415
    [No Abstract]   [Full Text] [Related]  

  • 30. Preliminary results of azathioprine therapy in severe rheumatic disease.
    Swannell AJ; Coomes EN; Matthias JQ
    Ann Rheum Dis; 1970 Mar; 29(2):192-3. PubMed ID: 5427420
    [No Abstract]   [Full Text] [Related]  

  • 31. [DNA-synthesizing lymphocytes in the blood of patients with disseminated lupus erythematosus, rheumatoid arthritis, and panarteritis nodosa (author's transl)].
    Huber C; Günther R; Michlmayr G; Huber H; Braunsteiner H
    Wien Klin Wochenschr; 1973 Feb; 85(6):92-5. PubMed ID: 4155172
    [No Abstract]   [Full Text] [Related]  

  • 32. Azathioprine.
    Huskisson EC
    Clin Rheum Dis; 1984 Aug; 10(2):325-32. PubMed ID: 6509884
    [No Abstract]   [Full Text] [Related]  

  • 33. [Collagen diseases].
    Katsuta Y; Matsuo H
    Nihon Rinsho; 1970 Jul; 28(7):1880-5. PubMed ID: 5466525
    [No Abstract]   [Full Text] [Related]  

  • 34. Macroglobulins in rheumatoid arthritis and allied diseases.
    Svartz N
    Semin Arthritis Rheum; 1971 Aug; 1(2):141-60. PubMed ID: 5155610
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of rheumatoid arthritis with immunosuppressive drugs. I. Clinical study.
    Moens C; Brocteur J
    Acta Rheumatol Scand; 1965; 11(3):212-20. PubMed ID: 4158235
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
    Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 38. Azathioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis.
    Kerstens PJ; Stolk JN; De Abreu RA; Lambooy LH; van de Putte LB; Boerbooms AA
    Arthritis Rheum; 1995 Jan; 38(1):142-5. PubMed ID: 7818564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics and the impact on treatment protocols in patients with rheumatoid arthritis.
    Ibrahim I; Owen SA; Barton A
    Expert Rev Clin Immunol; 2012 Aug; 8(6):509-11. PubMed ID: 22992143
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective depletion of Ig-bearing lymphocytes by cyclophosphamide in rheumatoid arthritis and systemic lupus erythematosus. Guidelines for dosage.
    Horwitz DA
    Arthritis Rheum; 1974; 17(4):363-74. PubMed ID: 4605097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.